The differential diagnosis for hemangioma, focal nodular hyperplasia (
FNH), and hepatocellular adenoma may be difficult. Reliable diagnosis
is mandatory for the decision of whether to apply surgery or observati
on. Experience with long-term observation in nonoperated patients with
hemangioma and FNH is limited. A group of 437 patients from a single
institution were analyzed with regard to a diagnostic algorithm, the i
ndications for surgery, and observation. There were 238 hemangiomas, 1
50 eases of FNH, 44 adenomas, and 5 mixed tumors. Of the 437 patients,
173 underwent surgery; 103 with hemangioma and 54 with FNH were obser
ved at our own institution, whereas 117 patients underwent follow-up e
lsewhere or were lost. Among the operated patients with confirmed hist
ology, a good diagnostic yield was found for a combination of ultrason
ography (US), contrast (bolus)-enhanced computed tomography (CT), and
labeled red blood cell (RBC) scanning: sensitivity 85.7%, specificity
100%, positive predictive value (PPV) 100%, negative predictive value
(NPV) 81.8%, and accuracy 91.3%. For FNH the combination of US and CT
plus cholescintigraphy showed a sensitivity 82.1%, specificity 97.1%,
PPV 95.8%, NPV 84.6%, and accuracy 90.3%. Surgical mortality was 0.6%.
Observation of patients with hemangioma and FNH for a median of 32 mo
nths revealed no increase in tumor size in 80% and a decrease in fewer
than 7%. There was no tumor rupture and no evidence of malignant tran
sformation. We concluded that liver hemangioma and FNH can be differen
tiated from adenoma with high sensitivity, specificity, and accuracy b
y labeled RBC scanning and cholescintigraphy in combination with US an
d contrast-enhanced CT. In the case of symptoms or an equivocal diagno
sis with respect to adenoma or hepatocellular carcinoma, surgery can b
e performed with very Low risk. Because in asymptomatic patients with
observed hemangioma or FNH no increase of tumor size can be expected f
or many years, the indications for surgery must be carefully evaluated
.